2026-04-18T01:19:16Zhttps://recercat.cat/oai/request

oai:recercat.cat:11351/57562024-12-13T11:10:39Zcom_2072_378070com_2072_378040col_2072_378092

Recommendations by the Spanish Society of Hospital Pharmacy, the Spanish Society of Oncology Nursing and the Spanish Society of Medical Oncology for the safe management of antineoplastic medication in cancer patients Vera, Ruth Otero, M. J. Ayala de la Peña, Francisco González-Pérez, C. Peñuelas Saiz, Angeles Sepúlveda, Juan Manuel Gorgas Torner, Maria Queralt [Vera R] Servicio de Oncología Médica, Complejo Hospitalario de Navarra, Calle Irunlarrea, 3, 31008 Pamplona, Navarra, Spain. [Otero MJ] Instituto para el Uso Seguro de los Medicamentos (ISMP-España), Servicio de Farmacia Hospitalaria, Hospital Universitario de Salamanca, Salamanca, Spain. [Ayala de la Peña F] Servicio de Hematología y Oncología Médica, Hospital General Universitario Morales Meseguer, Murcia, Spain. [González-Pérez C] Servicio de Farmacia Hospitalaria, Hospital Clínico San Carlos, Madrid, Spain. [Peñuelas Á] Direcció d’Infermeria, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Enfermería Ensayos Clínicos, Vall d’Hebron Institute de Oncology, Barcelona, Spain. [Sepúlveda JM] Servicio de Oncología Médica, Hospital Universitario Doce de Octubre, Madrid, Spain. [Gorgas MQ] Farmàcia, Vall d’Hebron Hospital Universitari, Barcelona, Spain Vall d'Hebron Barcelona Hospital Campus Medicaments antineoplàstics Oncologia Errors de medicació CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents Other subheadings::Other subheadings::Other subheadings::/adverse effects DISCIPLINES AND OCCUPATIONS::Health Occupations::Medicine::Internal Medicine::Medical Oncology ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Drug Therapy::Medication Errors COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antineoplásicos::antibióticos antineoplásicos Otros calificadores::Otros calificadores::Otros calificadores::/efectos adversos DISCIPLINAS Y OCUPACIONES::profesiones sanitarias::medicina::medicina interna::oncología médica TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::farmacoterapia::errores de medicación Errors de medicació; Prevenció i control; Seguretat del pacient Errores de medicación; Prevención y control; Seguridad del paciente Medication errors; Prevention and control; Patient safety Aim To define recommendations that permit safe management of antineoplastic medication, minimise medication errors and improve the safety of cancer patients undergoing treatment. Methods By reviewing the literature and consulting the websites of various health organisations and agencies, an expert committee from the Spanish Society of Hospital Pharmacy and the Spanish Society of Medical Oncology defined a set of safe practices covering all stages of providing cancer therapy to patients. The Spanish Society of Oncology Nursing revised and endorsed the final list. Results In total, 68 recommendations arranged in five sections were defined. They include issues concerning the training of health professionals, the technological resources needed, treatment planning, informing the patient and his/her family, the processes of prescribing, preparing, dispensing and administering cancer therapy (orally, parenterally or intrathecally), assessing patient adherence and treatment toxicity. Conclusions It is essential for healthcare establishments to implement specific measures designed to prevent medication errors, in order to ensure the safety of cancer patients treated with antineoplastic medication. This project was supported with unrestricted grants from SEFH and SEOM 2021-03-15T12:11:13Z 2021-03-15T12:11:13Z 2019-04 info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Vera R, Otero MJ, Ayala de la Peña F, González-Pérez C, Peñuelas, Sepúlveda JM, et al. Recommendations by the Spanish Society of Hospital Pharmacy, the Spanish Society of Oncology Nursing and the Spanish Society of Medical Oncology for the safe management of antineoplastic medication in cancer patients. Clin Transl Oncol. 2019 Apr;21(4):467–78. 1699-3055 https://hdl.handle.net/11351/5756 10.1007/s12094-018-1945-x 30298467 000461394500009 http://hdl.handle.net/11351/5756 eng Clinical and Translational Oncology;21(4) https://link.springer.com/article/10.1007/s12094-018-1945-x Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ info:eu-repo/semantics/openAccess application/pdf Springer Scientia